Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 | Industry: Pharmaceuticals
| Expensive Performer
213.5400 -0.32 (-0.15%)
NSE Dec 26, 2025 15:31 PM
Volume: 488.9K
 

213.54
-0.15%
BP Wealth
driven by positive operating leverage. During the quarter the company incurred one-time expenses of BSE code INR 90mn (onetime bonus and ESOPs of INR 52.1mn and INR 38.3mn related to discontinuation of Alivira France operations) under Exceptional item. SSL reported a PAT of INR 213mn compared to our estimate of INR 250mn. Adjusting onetime expenses, the Normalised PAT came in at INR297mn...
Sequent Scientific Ltd. is trading above its 200 day SMA of 184.8
More from Sequent Scientific Ltd.
Recommended